PREMIER Biosoft Announces Collaboration with University of Utah
News Aug 07, 2015
PREMIER Biosoft has announced that it has entered into a formal collaboration with the University of Utah to provide advanced mass spectrometry data analysis solutions for metabolomics and lipidomics.
Under the alliance, PREMIER Biosoft will work closely with the Metabolomics, Mass Spectrometry & Proteomics Core Facility at the University of Utah to power research in small molecules. Dr. James Cox, who heads the facility and currently serves as a Research Assistant Professor of Biochemistry & Core Director will work with PREMIER Biosoft to render more accurate data analysis using the experimental data and digital signatures observed. He has over 16 years of experience in MS arena with a Ph.D in Medicinal and Pharmaceutical Chemistry.
The University's core is equipped with a dozen high-performance mass spectrometers and provides expert mass spectrometry based consultation services for a broad range of research to various scientific communities.
Dr. Cox will offer his expertise by generating volumes of high throughput MS/MS data from different instrumentation platforms to assist PREMIER Biosoft in data interpretation, heuristics and strengthening the product databases.
Dr. Cox said, “Our objective is to offer a more robust analysis architecture to the software tools which are already delivering advance and complex data analysis solutions to further research in lipidomics and metabolomics”.
“The collaboration is based on a long-standing relationship with the University and Dr. James Cox. We look forward to taking this relationship to the next level through mutually beneficial research in small molecules,” said Arun Apte, CEO at PREMIER Biosoft.
Test For Designer Drugs Could Help Treat Overdose PatientsNews
Medical professionals are scrambling to meet the growing demand for emergency room treatment, but they’re hampered by the lack of a quick and easy test to screen patients for “designer” drugs. Chemists have now developed such a test and are refining it with the hope that hospitals could eventually use it to choose the appropriate treatment.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018
11th International Conference and Exhibition on Metabolomics & Systems Biology
May 17 - May 19, 2018
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018